NO20045469L - (S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav - Google Patents

(S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav

Info

Publication number: NO20045469L
Authority: NO; Norway
Prior art keywords: tetrahydrofurylcarbonyl; piperidinylmethyl; benzamide; piperidinyl; chloro
Prior art date: 2002-05-16

Application number

NO20045469A

Other languages

English (en)

Norwegian (no)

Inventor

Shiro Kato

Kazuo Morikage

Yukiko Morikage

Yoshimi Hirokawa

Naoyuki Yoshida

Hiroshi Yamazaki

Yoko Kan

Original Assignee

Dainippon Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-16

Filing date

2004-12-15

Publication date

2005-02-16

2004-12-15 Application filed by Dainippon Pharmaceutical Co filed Critical Dainippon Pharmaceutical Co

2005-02-16 Publication of NO20045469L publication Critical patent/NO20045469L/no

Links

MMAHZLJRNLZQCI-NRFANRHFSA-N 4-amino-5-chloro-2-methoxy-n-[1-[[1-[(2s)-oxolane-2-carbonyl]piperidin-4-yl]methyl]piperidin-4-yl]benzamide Chemical compound COC1=CC(N)=C(Cl)C=C1C(=O)NC1CCN(CC2CCN(CC2)C(=O)[C@H]2OCCC2)CC1 MMAHZLJRNLZQCI-NRFANRHFSA-N 0.000 title abstract 2
239000008194 pharmaceutical composition Substances 0.000 title abstract 2
239000000543 intermediate Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 abstract 2
230000000694 effects Effects 0.000 abstract 2
108091005482 5-HT4 receptors Proteins 0.000 abstract 1
101150049660 DRD2 gene Proteins 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
210000003169 central nervous system Anatomy 0.000 abstract 1
229960003638 dopamine Drugs 0.000 abstract 1
239000003623 enhancer Substances 0.000 abstract 1
230000002496 gastric effect Effects 0.000 abstract 1
230000005176 gastrointestinal motility Effects 0.000 abstract 1
230000003389 potentiating effect Effects 0.000 abstract 1
239000002325 prokinetic agent Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20045469A 2002-05-16 2004-12-15 (S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav NO20045469L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2002141262		2002-05-16
PCT/JP2003/006051 WO2003097638A1 (en)	2002-05-16	2003-05-15	(s)-4-amino-5-chloro-2-methoxy-n-[1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl]benzamide, process for the preparation thereof, pharmaceutical composition containing the same, and intermediate therefor

Publications (1)

Publication Number	Publication Date
NO20045469L true NO20045469L (no)	2005-02-16

Family

ID=29267809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20045469A NO20045469L (no)	2002-05-16	2004-12-15	(S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav

Country Status (26)

Country	Link
US (1)	US6696468B2 (cs)
EP (1)	EP1362857B1 (cs)
JP (1)	JP3643107B2 (cs)
KR (1)	KR20040107520A (cs)
CN (1)	CN1653063A (cs)
AR (1)	AR040021A1 (cs)
AT (1)	ATE273304T1 (cs)
AU (1)	AU2003230245A1 (cs)
BR (1)	BR0309933A (cs)
CA (1)	CA2483368A1 (cs)
CZ (1)	CZ20041084A3 (cs)
DE (1)	DE60300021T2 (cs)
DK (1)	DK1362857T3 (cs)
ES (1)	ES2227500T3 (cs)
HU (1)	HUP0501016A2 (cs)
IL (1)	IL165012A0 (cs)
MX (1)	MXPA04011332A (cs)
NO (1)	NO20045469L (cs)
PL (1)	PL372724A1 (cs)
PT (1)	PT1362857E (cs)
RU (1)	RU2004136853A (cs)
SK (1)	SK50192004A3 (cs)
TR (1)	TR200403020T2 (cs)
TW (1)	TW200400186A (cs)
WO (1)	WO2003097638A1 (cs)
ZA (1)	ZA200409053B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9904377D0 (sv) *	1999-12-01	1999-12-01	Astra Pharma Prod	Pharmaceutical combinations
SE0200843D0 (sv)	2002-03-19	2002-03-19	Astrazeneca Ab	Chemical compounds
SE0200844D0 (sv)	2002-03-19	2002-03-19	Astrazeneca Ab	Chemical compounds
SE0300957D0 (sv)	2003-04-01	2003-04-01	Astrazeneca Ab	Chemical compounds
TW200533348A (en) *	2004-02-18	2005-10-16	Theravance Inc	Indazole-carboxamide compounds as 5-ht4 receptor agonists
US7728006B2 (en) *	2004-04-07	2010-06-01	Theravance, Inc.	Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
US8309575B2 (en)	2004-04-07	2012-11-13	Theravance, Inc.	Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) *	2004-04-07	2011-11-01	Theravance Inc	Quinolinone-carboxamide compounds as 5-ht4 recepto
ATE441646T1 (de) *	2004-11-05	2009-09-15	Theravance Inc	5-ht4-rezeptoragonistenverbindungen
EP1807423B1 (en) *	2004-11-05	2009-05-20	Theravance, Inc.	Quinolinone-carboxamide compounds
ATE469897T1 (de) *	2004-12-22	2010-06-15	Theravance Inc	Indazolcarbonsäureamidverbindungen
NZ560828A (en) *	2005-03-02	2011-01-28	Theravance Inc	Quinolinone compounds as 5-HT4 receptor agonists
MY147756A (en)	2005-05-25	2013-01-15	Theravance Inc	Benzimidazole-carboxamide compounds as 5-ht4 receptor agonists
US7256294B2 (en) *	2005-05-25	2007-08-14	Theravance, Inc.	Crystalline form of a benzimidazole-carboxamide medicinal compound
EP1888527A1 (en) *	2005-05-27	2008-02-20	AstraZeneca AB	Piperidines for the treatment of chemokine mediated diseases
TW200722419A (en) *	2005-05-27	2007-06-16	Astrazeneca Ab	Chemical compounds
JP2009501793A (ja)	2005-07-21	2009-01-22	アストラゼネカ・アクチエボラーグ	新規ピペリジン誘導体
GB0525068D0 (en)	2005-12-08	2006-01-18	Novartis Ag	Organic compounds
TWI423967B (zh) *	2008-02-21	2014-01-21	Dainippon Sumitomo Pharma Co	醯胺衍生物及含有其之醫藥組合物
US8349852B2 (en)	2009-01-13	2013-01-08	Novartis Ag	Quinazolinone derivatives useful as vanilloid antagonists
AR080056A1 (es)	2010-02-01	2012-03-07	Novartis Ag	Derivados de ciclohexil-amida como antagonistas de los receptores de crf
JP2013518085A (ja)	2010-02-01	2013-05-20	ノバルティスアーゲー	ＣＲＦ−１受容体アンタゴニストとしてのピラゾロ［５，１ｂ］オキサゾール誘導体
JP5748777B2 (ja)	2010-02-02	2015-07-15	ノバルティスアーゲー	Ｃｒｆ受容体アンタゴニストとしてのシクロヘキシルアミド誘導体
UY34094A (es)	2011-05-27	2013-01-03	Novartis Ag	Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina
CA2867043A1 (en)	2012-05-03	2013-11-07	Novartis Ag	L-malate salt of 2,7-diaza-spiro[4.5]dec-7-yle derivatives and crystalline forms thereof as ghrelin receptor agonists
BR112022022184A2 (pt) *	2020-05-04	2023-01-17	Takeda Pharmaceuticals Co	Derivados de n-(piperidin-4-il)benzamida agindo luminalmente

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH111472A (ja)	1996-04-30	1999-01-06	Dainippon Pharmaceut Co Ltd	ベンズアミド誘導体及びそれを含有する医薬組成物
WO1999055674A1 (en) *	1998-04-28	1999-11-04	Dainippon Pharmaceutical Co., Ltd.	1-[(1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
JP2000080081A (ja)	1998-06-24	2000-03-21	Dainippon Pharmaceut Co Ltd	１―〔（１―置換―４―ピペリジニル）メチル〕―４―ピペリジン誘導体及びそれを含有する医薬組成物
JP2001122784A (ja)	1999-10-27	2001-05-08	Dainippon Pharmaceut Co Ltd	１−［（１−置換−４−ピペリジニル）メチル］−４−ピペリジン誘導体からなる医薬

2002
- 2002-12-18 US US10/321,615 patent/US6696468B2/en not_active Expired - Fee Related
2003
- 2003-01-03 DK DK03250050T patent/DK1362857T3/da active
- 2003-01-03 AT AT03250050T patent/ATE273304T1/de not_active IP Right Cessation
- 2003-01-03 DE DE60300021T patent/DE60300021T2/de not_active Expired - Fee Related
- 2003-01-03 ES ES03250050T patent/ES2227500T3/es not_active Expired - Lifetime
- 2003-01-03 PT PT03250050T patent/PT1362857E/pt unknown
- 2003-01-03 EP EP03250050A patent/EP1362857B1/en not_active Expired - Lifetime
- 2003-05-08 TW TW092112525A patent/TW200400186A/zh unknown
- 2003-05-15 KR KR10-2004-7018158A patent/KR20040107520A/ko not_active Withdrawn
- 2003-05-15 CZ CZ20041084A patent/CZ20041084A3/cs unknown
- 2003-05-15 TR TR2004/03020T patent/TR200403020T2/xx unknown
- 2003-05-15 IL IL16501203A patent/IL165012A0/xx unknown
- 2003-05-15 JP JP2003137413A patent/JP3643107B2/ja not_active Expired - Fee Related
- 2003-05-15 CN CNA03811089XA patent/CN1653063A/zh active Pending
- 2003-05-15 BR BR0309933-4A patent/BR0309933A/pt not_active Application Discontinuation
- 2003-05-15 MX MXPA04011332A patent/MXPA04011332A/es unknown
- 2003-05-15 CA CA002483368A patent/CA2483368A1/en not_active Abandoned
- 2003-05-15 WO PCT/JP2003/006051 patent/WO2003097638A1/en not_active Ceased
- 2003-05-15 PL PL03372724A patent/PL372724A1/xx not_active Application Discontinuation
- 2003-05-15 HU HU0501016A patent/HUP0501016A2/hu unknown
- 2003-05-15 AU AU2003230245A patent/AU2003230245A1/en not_active Abandoned
- 2003-05-15 RU RU2004136853/04A patent/RU2004136853A/ru not_active Application Discontinuation
- 2003-05-15 SK SK5019-2004A patent/SK50192004A3/sk unknown
- 2003-05-15 AR ARP030101702A patent/AR040021A1/es unknown
2004
- 2004-11-09 ZA ZA200409035A patent/ZA200409053B/en unknown
- 2004-12-15 NO NO20045469A patent/NO20045469L/no unknown

Also Published As

Publication number	Publication date
US6696468B2 (en)	2004-02-24
TW200400186A (en)	2004-01-01
US20030216433A1 (en)	2003-11-20
DE60300021D1 (de)	2004-09-16
AR040021A1 (es)	2005-03-09
EP1362857B1 (en)	2004-08-11
DE60300021T2 (de)	2005-09-08
PT1362857E (pt)	2004-11-30
RU2004136853A (ru)	2005-06-27
AU2003230245A1 (en)	2003-12-02
HUP0501016A2 (en)	2006-02-28
ZA200409053B (en)	2005-07-12
ATE273304T1 (de)	2004-08-15
CA2483368A1 (en)	2003-11-27
TR200403020T2 (tr)	2005-05-23
DK1362857T3 (da)	2004-12-20
JP2004043453A (ja)	2004-02-12
CZ20041084A3 (cs)	2005-02-16
BR0309933A (pt)	2005-02-09
MXPA04011332A (es)	2005-02-14
ES2227500T3 (es)	2005-04-01
JP3643107B2 (ja)	2005-04-27
HK1060118A1 (en)	2004-07-30
CN1653063A (zh)	2005-08-10
IL165012A0 (en)	2005-12-18
EP1362857A1 (en)	2003-11-19
WO2003097638A1 (en)	2003-11-27
PL372724A1 (en)	2005-07-25
KR20040107520A (ko)	2004-12-20
SK50192004A3 (sk)	2005-04-01

Publication	Publication Date	Title
NO20045469L (no)	2005-02-16	(S)-4-amino-5-klor-2-metoksy-N-[I-[ 1-(2-tetrahydrofurylkarbonyl)-4-piperidinylmetyl]-4-piperidinyl]benzamid, fremgangsmate for fremstilling, farmasoytiske sammensetninger inneholdende denne og intermediater derav
NO20045120L (no)	2004-12-07	Triazolderivater som takykininreseptorantagonister
NO20064151L (no)	2006-11-06	Nye forbindelser
NO20061519L (no)	2006-06-01	Benzimiflazolonforbindelser som har 5HT4-reseptorantagonistisk aktivitet
NO20055568L (no)	2006-01-20	Substituerte 1,4-diazepiner og anvendelser derav
WO2003064387A3 (en)	2004-12-02	Substituted indoles as alpha-1 agonists
DE602006017694D1 (de)	2010-12-02	C-verknüpfte zyklische antagonisten des p2y1-rezeptors mit eignung bei der behandlung thrombotischer leiden
NO20063748L (no)	2006-08-22	Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
NO20051036L (no)	2005-04-20	3,4-disubstituerte syklobuten-1,2-dioner som CXC-kjemokinreseptorligander
EA200301306A1 (ru)	2004-06-24	Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
CA2388142A1 (en)	2001-04-26	Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of p38 protein kinase
WO2003062248A3 (en)	2006-03-02	N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists
NO20051871L (no)	2005-04-18	Opioidreseptorantagonister
SE0302760D0 (sv)	2003-10-20	New compounds
WO2004048330A8 (en)	2005-10-27	N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
MXPA05013474A (es)	2006-03-09	Derivados de quinolilamida como antagonistas de ccr-5.
EA200601194A1 (ru)	2006-10-27	Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
NO20071372L (no)	2007-05-18	Nye polymorfer av azabisykloheksan
WO2005060959A8 (en)	2006-01-12	Pyrazole derivatives and use thereof as orexin receptor antagonists
DE60302157D1 (de)	2005-12-08	Opioidrezeptorantagonisten
NO20052676L (no)	2005-08-03	Polymorfer av bicifadin-saltsyre
WO2006113552A3 (en)	2007-05-31	Cyanoarylamines
WO2004041806A3 (en)	2004-08-05	Substituted 4-amino-1-(pyridylmethyl) piperidine as muscarinic receptor antagonists
NO20082938L (no)	2008-06-30	Formuleringer av quinolinoner
AP1766A (en)	2007-08-10	Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.